Autophagy, a key cellular auto-cleaning mechanism, mediates
the formation of amyloid beta plaques, one of the hallmarks of Alzheimer’s
disease. It might be a potential drug target for the treatment of the disease,
concludes new research from the RIKEN Brain Science Institute in Japan. The
study sheds light on the metabolism of amyloid beta, and its role in
neurodegeneration and memory loss.